Nutraceutical ingredients manufacturer Groupe Berkem and biotech company Arctic Bioscience have teamed up to launch B-Romega.
The herring caviar oil extract will be debuted to a North American audience, and will serve as a supplement designed to support overall health and wellbeing.
Groupe Berkem and Arctic Bioscience begun working together following the group's acquisition of Naturex Iberian Partners — Givaudan's industrial site in Valencia.
Together, the companies will introduce B-Romega to the North American market via B2B distribution channels.
According to the duo, B-Romega is a roe oil extract containing a rich source of pro-resolving mediators and phospholipids similar to DHA.
The functional ingredient acts as a crucial booster of cellular health, while also offering anti-inflammatory benefits to a user.
B-Romega is also upcycled from wild-caught herring, which are certified by the Marine Stewardship Council (MSC).
Amandine Brochot, Berkem Scientific Manager, said: “The collaboration between Berkem and Arctic Bioscience represents an exciting step forward in the field of Omega-3 supplements. B-Romega harnesses the natural benefits of phospholipid Omega-3 from herring caviar, offering superior bioavailability and proven health advantages."
"By uniting our expertise in marine extraction and scientific innovation, we are proud to deliver a product that not only supports human health but also reflects our shared commitment to sustainability and cutting-edge research.”
Kim Thorup, Arctic Bioscience Executive Vice-President, B2B Nutra, added: "From the very beginning, this partnership felt like a natural fit. Choosing Berkem as the Arctic Bioscience sales and distribution partner in North America made perfect sense, given the company’s know-how and experience in ingredient manufacturing, from raw material supply chain to in-house production processes."
